Search for:
facebook
twitter
Skip to content
Home
About Us
Management
Board of Directors
Pipeline
Upper Tract Urothelial Carcinoma
Low Grade Non Muscle Invasive Bladder Cancer
Carcinoma in Situ of the Bladder
Overactive Bladder
Interstitial Cystitis
Clinical Trials
Platforms
RTGel™
Immunotherapy
Investors
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Investor FAQs
Information Request
Contact Us
Contact
Investors
Home
»
Investors
»
SEC Filings
SEC Filings
SEC Filing Keyword Search
(
View search tips
)
Year Filter
All Years
2018
2017
Groupings Filter
(
View SEC Groupings descriptions
)
All Forms
3,4,5
Annual Filings
Current Reports
Other
Registration Statements
View Section 16 Filings (3,4,5)
<<
First
|
Previous
|
Next
|
Last
>>
Filing Date
Form
Description
Filing Group
Downloads
02/09/18
S-8
Securities offered to employees pursuant to employee benefit plans
Registration Statements
01/22/18
424B4
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3
Registration Statements
01/18/18
EFFECT
EFFECT
Other
01/18/18
F-1MEF
Registration of up to an additional 20% of securities for an offering filed on an F-1
Registration Statements
01/16/18
F-1
Registration statement for certain foreign private issuers
Registration Statements
01/11/18
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
01/08/18
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
12/14/17
6-K
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
12/11/17
SC 13G/A
An amendment to the SC 13G filing
Other
11/29/17
4
Statement of changes in beneficial ownership of securities
3,4,5
<<
First
|
Previous
|
Next
|
Last
>>
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Investor FAQs
Information Request
Contact Us
Print Page
E-mail Page
RSS Feeds
E-mail Alerts
Menu
Home
About Us
Management
Board of Directors
Pipeline
Upper Tract Urothelial Carcinoma
Low Grade Non Muscle Invasive Bladder Cancer
Carcinoma in Situ of the Bladder
Overactive Bladder
Interstitial Cystitis
Clinical Trials
Platforms
RTGel™
Immunotherapy
Investors
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Investor FAQs
Information Request
Contact Us
Contact
×